News >

Asymptomatic, Young Patients With MCL May Avoid Active Treatment

Angelica Welch
Published: Saturday, Sep 15, 2018

Simon Rule, MD, PhD

Simon Rule, MD, PhD
Frontline therapy may be able to be avoided in asymptomatic, young, fit patients with mantle cell lymphoma (MCL), explained Simon Rule, MD, PhD, in a presentation during the 2018 SOHO Annual Meeting. Active treatment in this patient population could potentially lead to unnecessary toxicities, he added. 
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication